Form 4: Zimmer Biomet Executive Mark Bezjak Reports Stock Transactions

Mark Bezjak, President, Americas at Zimmer Biomet Holdings, Inc., reports the vesting and disposal of restricted stock units to cover tax obligations.

Summary

• On March 6, 2025, Mark Bezjak, President, Americas at Zimmer Biomet Holdings, Inc., reported transactions involving Zimmer Biomet common stock.
• Bezjak acquired 1,621 shares of common stock through the vesting of restricted stock units (RSUs).
• Simultaneously, 638 shares were disposed of to satisfy tax withholding obligations at a price of $104.86 per share.
• Following these transactions, Bezjak directly owns 13,134 shares of common stock and 1,621 restricted stock units.
• The remaining RSUs will vest on March 6, 2026.

Sentiment

Score: 5

Explanation: The document is a neutral report of stock transactions, with no inherent positive or negative sentiment.

Future Outlook

The remaining RSUs will vest on March 6, 2026.

Industry Context

This Form 4 filing is a routine disclosure of stock transactions by a company executive, providing transparency to investors regarding insider activity. It is standard practice for executives to manage their equity compensation, including vesting of RSUs and selling shares to cover tax liabilities.

Key Dates